AMYLOIDOGENIC TRANSTHYRETIN (ATTR) AMYLOIDOSIS

Clinical trials for AMYLOIDOGENIC TRANSTHYRETIN (ATTR) AMYLOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new AMYLOIDOGENIC TRANSTHYRETIN (ATTR) AMYLOIDOSIS trials appear

Sign up with your email to follow new studies for AMYLOIDOGENIC TRANSTHYRETIN (ATTR) AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New PET scan aims to catch hidden heart disease

Diagnosis Not yet recruiting

This study tests whether a special PET-CT scan using a tracer called evuzamitide can detect signs of cardiac amyloidosis in people whose standard heart scans were unclear but who have high levels of a blood marker called TAD1. About 25 participants with heart failure or a genetic…

Matched conditions: AMYLOIDOGENIC TRANSTHYRETIN (ATTR) AMYLOIDOSIS

Sponsor: Lorena Saelices • Aim: Diagnosis

Last updated May 04, 2026 16:20 UTC

AMYLOIDOGENIC TRANSTHYRETIN (ATTR) AMYLOIDOSIS

Get alerted when new AMYLOIDOGENIC TRANSTHYRETIN (ATTR) AMYLOIDOSIS trials appear

New PET scan aims to catch hidden heart disease